Z-2591-2021Class II
MOSAIQ Oncology Information System
Elekta Limited / initiated 2021-09-02 / Open, Classified / root cause: software
Elekta, Inc. began a recall of MOSAIQ Oncology Information System on . FDA classified it as Class II and gives the reason as "A drug strength in MOSAIQ can be changed during the ordering process and approved, but the saved drug strength reverts to the original value". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.
Recall record
- Recall number
- Z-2591-2021
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- Elekta Limited
- Product
- MOSAIQ Oncology Information System
- Product code
- IYE Accelerator, Linear, Medical
- Reason for recall
- A drug strength in MOSAIQ can be changed during the ordering process and approved, but the saved drug strength reverts to the original value.
- Root cause tag
- software
- FDA root cause
- Software design
- Action
- The recalling firm issued an "URGENT IMPORTANT FIELD SAFETY NOTIFICATION" dated August 2021 via email to its consignees on 9/2/2021. Recommendations were made to the user until a fix is available.
- Quantity in commerce
- 31
- Distribution
- Distribution was made to CA, CO, FL, ID, LA, MO, MS, NC, NH, NM, NV, NY, OH, OK, PA, SD, and WA. There was no military/government distribution. Foreign distribution was made to Australia, Canada, and the United Kingdom.
- Product codes and lots
- MOSAIQ 2.83 when run with First Data Bank (FDB), UDI/GTIN MOSAIQ 2.83 (0858164002367)
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2591-2021 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
